ES2065911T3 - Produccion de proteinas en formas activas. - Google Patents

Produccion de proteinas en formas activas.

Info

Publication number
ES2065911T3
ES2065911T3 ES88305404T ES88305404T ES2065911T3 ES 2065911 T3 ES2065911 T3 ES 2065911T3 ES 88305404 T ES88305404 T ES 88305404T ES 88305404 T ES88305404 T ES 88305404T ES 2065911 T3 ES2065911 T3 ES 2065911T3
Authority
ES
Spain
Prior art keywords
protein production
active forms
host cells
proteins
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88305404T
Other languages
English (en)
Inventor
Joseph John Patroni
Malcolm Roy Brandon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Cross Biotech Pty Ltd
Original Assignee
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty Ltd filed Critical Southern Cross Biotech Pty Ltd
Application granted granted Critical
Publication of ES2065911T3 publication Critical patent/ES2065911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA LA RECUPERACION DE PROTEINAS QUE INCLUYE PROPORCIONAR UNA FUENTE DE CELULAS HUESPED QUE INCORPORAN UNA PROTEINA SINTETIZADA O EXPRESADA, Y UNA FUENTE DE AL MENOS UN TENSIOACTIVO CATIONICO, ANIONICO OANFOTERO Y TRATAR LAS CELULAS HUESPED CON AL MENOS UN TENSIOACTIVO CATIONICO, ANIONICO O ANFOTERO EN CANTIDAD SUFICIENTE PARA EFECTUAR LA SOLUBILIZACION DE LA PROTEINA DESEADA.
ES88305404T 1987-06-15 1988-06-14 Produccion de proteinas en formas activas. Expired - Lifetime ES2065911T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (1)

Publication Number Publication Date
ES2065911T3 true ES2065911T3 (es) 1995-03-01

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88305404T Expired - Lifetime ES2065911T3 (es) 1987-06-15 1988-06-14 Produccion de proteinas en formas activas.

Country Status (14)

Country Link
US (1) US4992531A (es)
JP (1) JPS6447389A (es)
KR (1) KR0126767B1 (es)
CN (1) CN1032425C (es)
AT (1) ATE114156T1 (es)
AU (1) AU609824B2 (es)
CA (1) CA1305284C (es)
DE (1) DE3852116T2 (es)
DK (1) DK322188A (es)
ES (1) ES2065911T3 (es)
IE (1) IE66334B1 (es)
NO (1) NO882635L (es)
NZ (1) NZ225032A (es)
ZA (1) ZA884212B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (ja) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 界面活性剤を用いたタンパク質の新規な精製法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
AU2003267245C1 (en) * 2002-09-20 2008-05-29 Promega Corporation Luminescence-based methods and probes for measuring cytochrome P450 activity
US7319021B2 (en) * 2002-11-01 2008-01-15 Promega Corporation Cell lysis composition, methods of use, apparatus and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
CN102807973A (zh) 2005-04-11 2012-12-05 萨文特医药公司 尿酸氧化酶的变体形式及其用途
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
DK3321359T3 (da) 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
EP2272973B1 (en) * 2005-05-31 2015-05-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US8617531B2 (en) * 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
US8288559B2 (en) * 2008-08-18 2012-10-16 Promega Corporation Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
GB0901434D0 (en) 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
CN102905690B (zh) 2010-05-21 2016-03-30 西门子医疗保健诊断公司 两性离子试剂
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
US10131898B2 (en) * 2014-07-22 2018-11-20 Bio-Rad Laboratories, Inc. Buffers for use with polymerases
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
CN1032425C (zh) 1996-07-31
DK322188D0 (da) 1988-06-14
JPS6447389A (en) 1989-02-21
CN88103725A (zh) 1988-12-28
NO882635D0 (no) 1988-06-15
DE3852116D1 (de) 1994-12-22
AU1763288A (en) 1988-12-15
ZA884212B (en) 1989-03-29
ATE114156T1 (de) 1994-12-15
NZ225032A (en) 1991-02-26
KR900000380A (ko) 1990-01-30
CA1305284C (en) 1992-07-14
KR0126767B1 (ko) 1997-12-29
DK322188A (da) 1988-12-17
AU609824B2 (en) 1991-05-09
DE3852116T2 (de) 1995-03-30
IE66334B1 (en) 1995-12-27
IE881815L (en) 1988-12-15
US4992531A (en) 1991-02-12
NO882635L (no) 1988-12-19

Similar Documents

Publication Publication Date Title
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
DK512686D0 (da) Thrombinpraeparater, deres fremstilling og anvendelse
NO864990D0 (no) Solubilisering av proteinaggregater.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
ATE114319T1 (de) Produktion von proteinen in aktiven formen.
ATE423208T1 (de) Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie
FI864654A0 (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
ES2155526T3 (es) Proteinas que se dirigen al interior de viriones de hiv basadas en moleculas de fusion vpr de hiv-1.
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
FR2662698B1 (es)
SE8801701D0 (sv) Production technology based on enzymic method
ES2016920A4 (es) Procedimiento de realizacion de barras anti-torsion por encolado in situ de cojinetes elasticos y barras anti-torsion realizadas segun el procedimiento.
MY103362A (en) Production of proteins in active forms
BR8707482A (pt) Processo para controle de bioincrustacao em sistema aquoso,composicao biocidamente ativa e composicao
ES2119779T3 (es) Solubilizacion de proteinas en formas activas.
IT7928414A0 (it) Procedimento per controllare, impostare e pilotare unita' dilavoro, in particolare unita' difilatura, o macchine che ne sono dotate, e dispositivo per effettuare tale procedimento.
FI872310A7 (fi) Menetelmä indiumin, germaniumin ja/tai galliumin talteenottamiseksi.
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
ATE188355T1 (de) Kleiderbügel
MY103305A (en) Productions of proteins in active forms
GR3003950T3 (es)
RU2005185C1 (ru) Проходческий щит

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295859

Country of ref document: ES